Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maxensia Owor
Observed names:
M. Owor,
Maxensia A Owor,
Owor, Maxensia
Institution:
MUJHU Research Collaboration
Observed institutions:
Johns Hopkins University,
George Washington University,
Johns Hopkins Medicine,
Fred Hutch Cancer Center,
MUJHU Research Collaboration,
Makerere University
show all 6
ORCID:
0009-0001-3206-9059
Observed ORCID:
0009-0001-3206-9059
OpenAlex ID:
A5066010404
Works
55
Awards
1
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial
2003
·
J Brooks Jackson
, Philippa Musoke
, et al.
·
The Lancet
·
575
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
2016
·
Mary G. Fowler
, Min Qin
, et al.
·
New England Journal of Medicine
·
400
PDF
Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial
2017
·
Patricia M. Flynn
, Taha E. Taha
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
254
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
2023
·
Neal J. Russell
, Wolfgang Stöhr
, et al.
·
PLoS Medicine
·
239
PDF
Association of Maternal Viral Load and CD4 Count With Perinatal HIV-1 Transmission Risk During Breastfeeding in the PROMISE Postpartum Component
2021
·
Patricia M. Flynn
, Taha E. Taha
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
74
Perinatal HIV and Its Prevention: Progress Toward an HIV-free Generation
2010
·
Mary Glenn Fowler
, Alicia R. Gable
, et al.
·
Clinics in Perinatology
·
52
Intrapartum and Neonatal Single-Dose Nevirapine Compared With Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-Month Follow Up of the HIVNET 012 Randomized Trial
2004
·
J. Brooks Jackson
, Philippa Musoke
, et al.
·
Obstetrical & Gynecological Survey
·
50
Pregnancy Outcomes of Women Conceiving on Antiretroviral Therapy (ART) Compared to Those Commenced on ART During Pregnancy
2020
·
Gerhard Theron
, Sean Brummel
, et al.
·
Clinical Infectious Diseases
·
43
Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial
2019
·
Dorothy Sebikari
, Mona Farhad
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
30
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected Infants
2021
·
Ceejay L Boyce
, Tatiana Sils
, et al.
·
Clinical Infectious Diseases
·
27
Long-Term Follow-Up of Children in the HIVNET 012 Perinatal HIV Prevention Trial: Five-Year Growth and Survival
2013
·
Maxensia Owor
, Anthony Mwatha
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
27
Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women
2019
·
Pamela M. Murnane
, Peter Bacchetti
, et al.
·
AIDS
·
17
Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial
2025
·
Lisa M Noguchi
, Maxensia Owor
, et al.
·
The Lancet HIV
·
16
Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants
2024
·
Hannah G Davies
, Mary Kyohere
, et al.
·
Open Forum Infectious Diseases
·
11
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda
2023
·
Marie C. D. Stoner
, Imogen Hawley
, et al.
·
AIDS and Behavior
·
11
PDF
Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial
2023
·
Tichaona Vhembo
, Kristin Baltrusaitis
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
11
Twenty years of Prevention of Mother to Child HIV Transmission: research to implementation at a national referral hospital in Uganda
2022
·
Emily Namara-Lugolobi
, Zikulah Namukwaya
, et al.
·
African Health Sciences
·
10
PDF
Epidemiology of Group B Streptococcus : Maternal Colonization and Infant Disease in Kampala, Uganda
2025
·
Mary Kyohere
, Hannah Georgia Davies
, et al.
·
Open Forum Infectious Diseases
·
9
Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir–rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study
2026
·
Aditya H Gaur
, Kristin Baltrusaitis
, et al.
·
The Lancet HIV
·
8
PDF
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India
2022
·
Neetal Nevrekar
, Kevin Butler
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
8
Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
2022
·
Kristin Baltrusaitis
, Bonus Makanani
, et al.
·
BMC Infectious Diseases
·
8
PDF
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092
2021
·
Maxensia Owor
, Camlin Tierney
, et al.
·
The Pediatric Infectious Disease Journal
·
8
Brief Report: Characterizing HIV Drug Resistance in Cases of Vertical Transmission in the VESTED Randomized Antiretroviral Treatment Trial
2024
·
Marley D. Bishop
, Violet Korutaro
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
7
PDF
Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study
2019
·
Eliza D. Hompe
, Denise L. Jacobson
, et al.
·
mSphere
·
7
Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention
2017
·
Mary G. Fowler
, Min Qin
, et al.
·
Obstetrical & Gynecological Survey
·
7
Show more works
View as search
Works count:
55
Citation count:
1,976
H-index:
13
I10-index:
17
Year
Topic
Type